Company / Free Cash Flow
SELLAS Life Sciences Group, Inc. Free Cash Flow History
FY2015-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$11.9M
FY2016
5-year range
-
FY2015-FY2016
Trend
+75.5%
vs FY2015
Sector context
#69 of 194
Health Care
What the data says
At -$12M, SELLAS Life Sciences Group, Inc.'s free cash flow ranks #69 of 194 in the Health Care sector.
Based on SEC 10-K filings.
-$12M in FY2016.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#69 of 194 in Health CareTop 36% of 194This company -$11.9M Sector average $470.6M
▼
-102.5% below sector average
Key checks
Key Insights
- In FY2016, free cash flow increased 75.5% year-over-year.
- Ranks #69 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | -$11.9M | +75.5% |
| FY2015 | -$48.3M | -12.5% |
As of FY2016 · SEC 10-K · Updated Jun 30, 2026